Free Trial
NASDAQ:VIVE

Viveve Medical (VIVE) Stock Price, News & Analysis

Viveve Medical logo
$0.0003 0.00 (-70.00%)
(As of 12/20/2024 01:26 PM ET)

About Viveve Medical Stock (NASDAQ:VIVE)

Key Stats

Today's Range
$0.0003
$0.0004
50-Day Range
N/A
52-Week Range
$0.00
$0.04
Volume
7,330 shs
Average Volume
3,327 shs
Market Capitalization
$3,201.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Receive VIVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

VIVE Stock News Headlines

Viveve Medical Inc (VIVE)
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Vaginal Rejuvenation Is Big Business
VIVE Viveve Medical, Inc.
See More Headlines

VIVE Stock Analysis - Frequently Asked Questions

Viveve Medical's stock was trading at $0.0002 at the start of the year. Since then, VIVE stock has increased by 50.0% and is now trading at $0.0003.
View the best growth stocks for 2024 here
.

Viveve Medical, Inc. (NASDAQ:VIVE) issued its quarterly earnings data on Thursday, November, 11th. The company reported ($0.67) earnings per share for the quarter, missing analysts' consensus estimates of ($0.58) by $0.09. The business earned $1.62 million during the quarter.

Viveve Medical (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), NIO (NIO) and Western Digital (WDC).

Company Calendar

Last Earnings
11/11/2021
Today
12/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:VIVE
Previous Symbol
OTCMKTS:PLCSD
Employees
47
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.83 million

Miscellaneous

Free Float
N/A
Market Cap
$3,201.00
Optionable
Not Optionable
Beta
0.71

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:VIVE) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners